These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3128452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of a high-purity factor VIII concentrate (Hemate P) in von Willebrand's disease.
    Berntorp E, Nilsson IM.
    Vox Sang; 1989; 56(4):212-7. PubMed ID: 2503935
    [Abstract] [Full Text] [Related]

  • 5. Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
    Morfini M, Longo G, Matucci M, Vannini S, Messori A, Filimberti E, Duminuco M, Avanzi G, Rossi-Ferrini P.
    Ric Clin Lab; 1984; 14(4):681-91. PubMed ID: 6441235
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
    Tanaka I, Yoshioka A, Shima M, Fujiwara T, Terada S, Nakai H, Miyata S, Sawamoto Y, Kamisue S, Fukui H.
    Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of the pharmacokinetics of three monoclonal factor VIII concentrates.
    Morfini M, Mannucci PM, Longo G, Cinotti S, Messori A.
    Thromb Res; 1991 Feb 01; 61(3):285-90. PubMed ID: 1902997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characteristics of the von Willebrand factor in virus inactivated F VIII concentrates: the impact of heat treatment.
    Ingerslev J, Bukh A, Wallevik K, Møller NP, Stenbjerg S.
    Thromb Res; 1987 Jul 15; 47(2):175-82. PubMed ID: 3116714
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of von Willebrand factor in factor VIII concentrates.
    Fricke WA, Yu MY.
    Am J Hematol; 1989 May 15; 31(1):41-5. PubMed ID: 2495715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentrates.
    Lawrie AS, Harrison P, Armstrong AL, Wilbourn BR, Dalton RG, Savidge GF.
    Br J Haematol; 1989 Sep 15; 73(1):100-4. PubMed ID: 2508742
    [Abstract] [Full Text] [Related]

  • 20. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.
    Tuddenham EG, Lane RS, Rotblat F, Johnson AJ, Snape TJ, Middleton S, Kernoff PB.
    Br J Haematol; 1982 Oct 15; 52(2):259-67. PubMed ID: 6812613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.